Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review

Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review

<b>Background and Objectives:</b> Systemic conversion of stage III–IV non-small-cell lung cancer (NSCLC) to a surgically resectable state with immune checkpoint inhibitors (ICIs) or tyrosine kinase inhibitors (TKIs) creates an emerging cohort of candidates for “salvage” pulmonary resecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasile Gaborean, Catalin Vladut Ionut Feier, Razvan Constantin Vonica, Alaviana Monique Faur, Vladut Iosif Rus, Calin Muntean
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Biomedicines
Subjects:
salvage surgery
immune checkpoint inhibitor
tyrosine kinase inhibitor
conversion therapy
non-small-cell lung cancer
Online Access:https://www.mdpi.com/2227-9059/13/7/1541
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items